Cargando…
Personalized treatment supported by automated quantitative fluid analysis in active neovascular age-related macular degeneration (nAMD)—a phase III, prospective, multicentre, randomized study: design and methods
INTRODUCTION: In neovascular age-related macular degeneration (nAMD) the exact amount of fluid and its location on optical coherence tomography (OCT) have been defined as crucial biomarkers for disease activity and therapeutic decisions. Yet in the absence of quantitative evaluation tools, real-worl...
Autores principales: | Coulibaly, Leonard M., Sacu, Stefan, Fuchs, Philipp, Bogunovic, Hrvoje, Faustmann, Georg, Unterrainer, Christian, Reiter, Gregor S., Schmidt-Erfurth, Ursula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255834/ https://www.ncbi.nlm.nih.gov/pubmed/35790835 http://dx.doi.org/10.1038/s41433-022-02154-8 |
Ejemplares similares
-
New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
por: Patel, Prem, et al.
Publicado: (2021) -
Correlation of vascular and fluid‐related parameters in neovascular age‐related macular degeneration using deep learning
por: Schranz, Markus, et al.
Publicado: (2022) -
Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence
por: Bogunović, Hrvoje, et al.
Publicado: (2022) -
Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD)
por: Sarkar, Aira, et al.
Publicado: (2021) -
Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
por: Tan, Colin S, et al.
Publicado: (2022)